Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three sessions, experts believe the panic is unfounded, maintaining confidence in the sectors' long-term outlook. Trump's recent 25% tariffs on auto exports to the US, along with additional duties, have further affected market sentiment.
For more details: Click here